Skip to content

Ingevity NGVT Restricted investment, restricted cash

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.53B+73.9%
Enterprise value$3.8B+32.4%
P/S2.1×+0.9×

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept ngvt:RestrictedInvestmentRestrictedCash.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's restricted investment, restricted cash.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's restricted investment, restricted cash?
Ingevity (NGVT) reported restricted investment, restricted cash of $59.4M in Q1 2026.
How has Ingevity's restricted investment, restricted cash changed year-over-year?
Ingevity's restricted investment, restricted cash increased by 214.3% year-over-year, from $18.9M to $59.4M.
What is the long-term trend for Ingevity's restricted investment, restricted cash?
Over 5 years (2020 to 2025), Ingevity's restricted investment, restricted cash has grown at a 69.9% compound annual growth rate (CAGR), from $2.4M to $34M.